Publikationen, an denen er mitarbeitet Lorenzo Rivas García (8)

2023

  1. Elucidating the Therapeutic Potential of Bis(Maltolato)OxoVanadium(IV): The Protective Role of Copper in Cellular Metabolism

    International Journal of Molecular Sciences, Vol. 24, Núm. 11

2022

  1. Effect of Bis(maltolato)oxovanadium(IV) on Zinc, Copper, and Manganese Homeostasis and DMT1 mRNA Expression in Streptozotocin-Induced Hyperglycemic Rats

    Biology, Vol. 11, Núm. 6

2021

  1. Cellular toxicity mechanisms and the role of autophagy in Pt(IV) prodrug-loaded ultrasmall iron oxide nanoparticles used for enhanced drug delivery

    Pharmaceutics, Vol. 13, Núm. 10

  2. Ultra-small iron nanoparticles target mitochondria inducing autophagy, acting on mitochondrial dna and reducing respiration

    Pharmaceutics, Vol. 13, Núm. 1, pp. 1-18

  3. Vanadium decreases hepcidin mrna gene expression in stz-induced diabetic rats, improving the anemic state

    Nutrients, Vol. 13, Núm. 4

2020

  1. In vitro and in situ experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements

    Nanotoxicology, Vol. 14, Núm. 3, pp. 388-403

  2. In vitro study of the protective effect of manganese against vanadium-mediated nuclear and mitochondrial DNA damage

    Food and Chemical Toxicology, Vol. 135

2014

  1. Exposure to bis(maltolato)oxovanadium(IV) increases levels of hepcidin mRNA and impairs the homeostasis of iron but not that of manganese

    Food and Chemical Toxicology, Vol. 73, pp. 113-118